By Professor Monica M. Lahra

Journal articles

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Meningococcal Surveillance Australia Reporting period 1 January to 31 March 2020', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.65

George CRR; Kundu RL; Whiley DM; Lahra MM, 2020, 'Are sex norms the norm in gonococcal surveillance?', Lancet Microbe, 1, pp. e143 - e144, http://dx.doi.org/10.1016/S2666-5247(20)30087-2

Khoo P; Cabrera-Aguas MP; Nguyen V; Lahra MM; Watson SL, 2020, 'Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation', Graefe S Archive for Clinical and Experimental Ophthalmology, 258, pp. 1745 - 1755, http://dx.doi.org/10.1007/s00417-020-04681-0

Lahra MM; Shoushtari M; George CRR; Armstrong BH; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme Annual Report, 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.58

Lahra MM; Shoushtari M; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 January to 31 March 2020', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.61

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.47

Lahra MM; Hogan TR, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.50

Lahra MM; Hogan TR, 2020, 'Australian Gonococcal Surveillance Programme, 1 April to 30 June 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.37

Lahra MM; Enriquez RP; Hogan TP, 2020, 'Australian Meningococcal Surveillance Programme annual report, 2018', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.10

Cabrera-Aguas M; Khoo P; George CRR; Lahra MM; Watson SL, 2020, 'Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia', Clinical and Experimental Ophthalmology, 48, pp. 183 - 191, http://dx.doi.org/10.1111/ceo.13672

Fifer H; Hughes G; Whiley D; Lahra MM, 2020, 'Lessons learnt from ceftriaxone-resistant gonorrhoea in the UK and Australia', Lancet Infectious Diseases, 20, pp. 276 - 278, http://dx.doi.org/10.1016/S1473-3099(20)30055-4

Lahra MM; Enriquez RP; George CRR, 2020, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2018', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.5

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 January to 31 March 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.3

Lahra MM; Enriquez RP; George CRR, 2020, 'Australian Gonococcal Surveillance Programme Annual Report, 2018', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.4

Lahra MM; Enriquez RP, 2020, 'Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2019', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2020.44.9

Gilbey T; McIver C; Brandenburg U; Goeman E; Polkinghorne A; Lahra M; Branley J, 2020, 'Suspected materno-fetal transmission of neisseria meningitidis serogroup w clonal complex 11 causing early- onset neonatal sepsis', Open Forum Infectious Diseases, 7, http://dx.doi.org/10.1093/ofid/ofaa039

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 April to 30 June 2017', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2019.44.7

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 January to 31 March 2017', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2019.44.8

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 July to 30 September 2017', COMMUNICABLE DISEASES INTELLIGENCE, 44, http://dx.doi.org/10.33321/cdi.2020.44.6

Lahra MM; Enriquez RP, 2020, 'Australian Gonococcal Surveillance Programme 1 July to 30 September 2017', Communicable Diseases Intelligence 2018, 44, http://dx.doi.org/10.33321/cdi.2019.44.6

Badahdah AM; Bakarman MA; Khatami A; Tashani M; Barasheed O; Alfelali M; Azeem MI; Bokhary H; Soltan O; Lahra MM; Jeoffreys N; Kok J; Dwyer DE; Booy R; Rashid H, 2020, 'Meningococcal and pneumococcal carriage in Hajj pilgrims: Findings of a randomized controlled trial', Journal of Travel Medicine, 27, http://dx.doi.org/10.1093/JTM/TAAA032

Watson SL; Cabrera-Aguas M; Keay L; Khoo P; McCall D; Lahra MM, 2020, 'The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia', Mycoses, 63, pp. 43 - 51, http://dx.doi.org/10.1111/myc.13009

Lahra MM; Enriquez RP, 2019, 'Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2017.', Commun Dis Intell (2018), 43, http://dx.doi.org/10.33321/cdi.2019.43.62

Khoo P; Cabrera-Aguas M; Robaei D; Lahra MM; Watson S, 2019, 'Microbial Keratitis and Ocular Surface Disease: A 5-Year Study of the Microbiology, Risk Factors and Clinical Outcomes in Sydney, Australia', Current Eye Research, 44, pp. 1195 - 1202, http://dx.doi.org/10.1080/02713683.2019.1631852

Hanrahan JK; Hogan TR; Buckley C; Trembizki E; Mitchell H; Lau CL; Whiley DM; Lahra MM, 2019, 'Emergence and spread of ciprofloxacin-resistant Neisseria gonorrhoeae in New South Wales, Australia: lessons from history', Journal of Antimicrobial Chemotherapy, 74, pp. 2214 - 2219, http://dx.doi.org/10.1093/jac/dkz182

Roczo-Farkas S; Cowley D; Bines JE; Bradbury S; Malinsky E; Rawlinson W; Lahra M; Merif J; Kesson A; Tam I; Sintchenko V; Olna T; Givney R; Pearce S; Delves K; Spence D; Wehrhahn M; Karimi M; Cook H; Moore F; McMahon J; Nimmo G; Bletchly C; George N; Lambert S; Dang L; Gilmore G; Higgins G; Schepetiuk S; Williamson J; Buttery J; Kotsanas D; Adamopolous P; Hrysoudis E; Gray F; Quach R; Smith D; Levy A; Lang J, 2019, 'Australian Rotavirus Surveillance Program : Annual Report, 2017', COMMUNICABLE DISEASES INTELLIGENCE, 43, http://dx.doi.org/10.33321/cdi.2019.43.28

Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D; Cunningham P; Wand H; Donovan B; Kaldor J; Conway D; Ryder N; McNulty A; Templeton D; Guy R; Lahra M; Gunathilake M, 2019, 'Evaluation of the ResistancePlus GC (beta) assay: A commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae', Journal of Antimicrobial Chemotherapy, 74, pp. 1820 - 1824, http://dx.doi.org/10.1093/jac/dkz108

Lahra MM; Enriquez R; George CRR, 2019, 'Australian Gonococcal Surveillance Programme Annual Report, 2017', Communicable Diseases Intelligence 2018, 43, http://dx.doi.org/10.33321/cdi.2019.43.13

George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo YR; Ishikawa N; Wi T; Lahra MM, 2019, 'Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016', Plos One, 14, http://dx.doi.org/10.1371/journal.pone.0213312

Jennison AV; Whiley D; Lahra MM; Graham RM; Cole MJ; Hughes G; Fifer H; Andersson M; Edwards A; Eyre D, 2019, 'Genetic relatedness of ceftriaxone-resistant and highlevel azithromycin resistant Neisseria gonorrhoeae cases, United Kingdom and Australia, February to April 2018', Eurosurveillance, 24, http://dx.doi.org/10.2807/1560-7917.ES.2019.24.8.1900118

Yeo KT; Lahra M; Bajuk B; Hilder L; Abdel-Latif ME; Wright IM; Oei JL, 2019, 'Long-term outcomes after group B streptococcus infection: A cohort study', Archives of Disease in Childhood, 104, pp. 172 - 178, http://dx.doi.org/10.1136/archdischild-2017-314642

Kiatchoosakun P; Jirapradittha J; Sirikarn P; Laopaiboon M; Pattanittum P; Chandrakachorn W; Srirojana S; Jeffery H; Green S; Lumbiganon P, 2019, 'Early-Onset Neonatal Sepsis and Antibiotic Use in Northeast Thailand', American Journal of Perinatology, 36, pp. 1295 - 1303, http://dx.doi.org/10.1055/s-0038-1676829

Buckley C; Beatson SA; Limnios A; Lahra MM; Whiley DM; Forde BM, 2019, 'Whole-genome sequencing as an improved means of investigating Neisseria gonorrhoeae treatment failures', Sexual Health, 16, pp. 500 - 507, http://dx.doi.org/10.1071/SH19012

Unemo M; Lahra MM; Cole M; Galarza P; Ndowa F; Martin I; Dillon JAR; Ramon-Pardo P; Bolan G; Wi T, 2019, 'World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): Review of new data and evidence to inform international collaborative actions and research efforts', Sexual Health, 16, pp. 412 - 425, http://dx.doi.org/10.1071/SH19023

George CRR; Enriquez RP; Gatus BJ; Whiley DM; Lo Y-R; Ishikawa N; Wi T; Lahra MM, 2019, 'Systematic review and survey of neisseria gonorrhoeae antimicrobial resistance data in the Asia Pacific, 2011 to 2016', Pathology, 51, pp. S136 - S136, http://dx.doi.org/10.1016/j.pathol.2018.12.395

Buckley C; Forde BM; Trembizki E; Lahra MM; Beatson SA; Whiley DM, 2018, 'Use of whole genome sequencing to investigate an increase in Neisseria gonorrhoeae infection among women in urban areas of Australia', Scientific Reports, 8, http://dx.doi.org/10.1038/s41598-018-20015-x

Regan DG; Hui BB; Wood JG; Fifer H; Lahra MM; Whiley DM, 2018, 'Treatment for pharyngeal gonorrhoea under threat', Lancet Infectious Diseases, 18, pp. 1175 - 1177, http://dx.doi.org/10.1016/S1473-3099(18)30610-8

Whiley DM; Mhango L; Jennison AV; Nimmo G; Lahra MM, 2018, 'Direct detection of penA gene associated with ceftriaxone-resistant neisseria gonorrhoeae FC428 strain by using PCR', Emerging Infectious Diseases, 24, pp. 1573 - 1575, http://dx.doi.org/10.3201/eid2408.180295

Whiley DM; Jennison A; Pearson J; Lahra MM, 2018, 'Genetic characterisation of Neisseria gonorrhoeae resistant to both ceftriaxone and azithromycin', Lancet Infectious Diseases, 18, pp. 717 - 718, http://dx.doi.org/10.1016/S1473-3099(18)30340-2

Whiley DM; Kundu RL; Jennison AV; Buckley C; Limnios A; Hogan T; Enriquez R; El Nasser J; Robert George C; Lahra MM, 2018, 'Azithromycin-resistant Neisseria gonorrhoeae spreading amongst men who have sex with men (MSM) and heterosexuals in New South Wales, Australia, 2017', Journal of Antimicrobial Chemotherapy, 73, pp. 1242 - 1246, http://dx.doi.org/10.1093/jac/dky017

Lahra MM; Martin I; Demczuk W; Jennison AV; Lee KI; Nakayama SI; Lefebvre B; Longtin J; Ward A; Mulvey MR; Wi T; Ohnishi M; Whiley D, 2018, 'Cooperative recognition of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain', Emerging Infectious Diseases, 24, pp. 735 - 740, http://dx.doi.org/10.3201/eid2404.171873

Lahra MM; Enriquez R, 2018, 'Australian Gonococcal Surveillance Programme Annual Report, 2016', Communicable Diseases Intelligence 2018, 42

Watson S; Cabrera-Aguas M; Khoo P; Pratama R; Gatus BJ; Gulholm T; El-Nasser J; Lahra MM, 2018, 'Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 Annual Report', Clinical and Experimental Ophthalmology, 47, pp. 20 - 25, http://dx.doi.org/10.1111/ceo.13364

George CRR; Rockett R; Whiley DM; Enriquez RP; Kundu R; El-Nasser J; Sintchenko V; Lahra MM, 2018, 'Whole genome sequencing to characterise azithromycin resistant Neisseria gonorrhoeae from New South Wales in 2017', Pathology, 50, pp. S51 - S51, http://dx.doi.org/10.1016/j.pathol.2017.12.117

Lahra MM; Enriquez R, 2017, 'Australian Meningococcal Surveillance Programme annual report, 2016', Communicable Diseases Intelligence Quarterly Report, 41, pp. E369 - E382

Archer BN; Chiu CK; Jayasinghe SH; Richmond PC; McVernon J; Lahra MM; Andrews RM; McIntyre PB; Nissen M; Campbell-Lloyd S; Peterson K; Koehler A; Leask J, 2017, 'Epidemiology of invasive meningococcal b disease in Australia, 1999-2015: Priority populations for vaccination', Medical Journal of Australia, 207, pp. 382 - 387, http://dx.doi.org/10.5694/mja16.01340

Lahra MM; Enriquez R, 2017, 'Australian Meningococcal Surveillance Programme, 1 April to 30 June 2017', Communicable Diseases Intelligence Quarterly Report, 41, pp. E241 - E242

Whiley DM; Trembizki E; Buckley C; Freeman K; Baird RW; Beaman M; Chen M; Donovan B; Kundu RL; Fairley CK; Guy R; Hogan T; Kaldor JM; Karimi M; Limnios A; Regan DG; Ryder N; Su JY; Ward J; Lahra MM, 2017, 'Molecular antimicrobial resistance surveillance for Neisseria gonorrhoeae, Northern Territory, Australia', Emerging Infectious Diseases, 23, pp. 1478 - 1485, http://dx.doi.org/10.3201/eid2309.170427

Wi T; Lahra MM; Ndowa F; Bala M; Dillon JAR; Ramon-Pardo P; Eremin SR; Bolan G; Unemo M, 2017, 'Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action', Plos Medicine, 14, pp. e1002344, http://dx.doi.org/10.1371/journal.pmed.1002344

Alirol E; Wi TE; Bala M; Bazzo ML; Chen XS; Deal C; Dillon JAR; Kularatne R; Heim J; Hooft van Huijsduijnen R; Hook EW; Lahra MM; Lewis DA; Ndowa F; Shafer WM; Tayler L; Workowski K; Unemo M; Balasegaram M, 2017, 'Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines', Plos Medicine, 14, http://dx.doi.org/10.1371/journal.pmed.1002366

Back to profile page